Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Boston Scientific Pays $523 Million for Control of Acotec, a Beijing Device Company

publication date: Dec 13, 2022

Boston Scientific will pay $523 million for a 65% stake in Acotec Scientific, a Beijing medical device company that offers cardiovascular devices. Acotec has developed a portfolio of drug-coated balloons and percutaneous transluminal angioplasty hardware, as well as radiofrequency ablation catheters. The offering price was 32% over the previous close and 136% over the average close for the last 150 days. Boston Scientific said the acquisition will build its China presence in while it will bring Acotec’s products to western markets. More details....

Stock Symbols: (NSDQ: BSX) (HK: 6669)

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital